# Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors

> **NCT05234762** · PHASE2 · UNKNOWN · sponsor: **ES Therapeutics Australia Pty Ltd** · enrollment: 24 (estimated)

## Conditions studied

- Tremor, Essential

## Interventions

- **DRUG:** ES-481
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05234762
- **Lead sponsor:** ES Therapeutics Australia Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-21
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05234762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05234762, "Efficacy, Safety, and Pharmacokinetics of ES-481 in Adult Patients With Essential Tremors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05234762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*